Pasar al contenido principal

Resultados relacionados

Resultados totales (Incluyendo duplicados): 11
Encontrada(s) 1 página(s)

Dipòsit Digital de Documents de la UAB
Publicación Artículo científico (JournalArticle)

Validation of a pregnancy-adapted Mediterranean Diet Adherence Screener (preg-MEDAS), a validation study nested in the Improving Mothers for a better PrenAtal Care Trial BarCeloNa (IMPACT BCN) trial

  • Castro Barquero, Sara|||0000-0002-6876-5443
  • Crovetto, Francesca|||0000-0003-0140-7411
  • Estruch, Ramón|||0000-0003-1260-4445
  • Ruiz-León, Ana María
  • Larroya, Marta|||0000-0001-7929-6630
  • Sacanella, Emilio|||0000-0001-8018-1523
  • Casanovas-Garriga, Francesc
  • Casas, Irene
  • Nakaki, Ayako|||0000-0002-4395-3878
  • Youssef, Lina|||0000-0002-0554-5507
  • Trejo-Domínguez, Alejandra|||0000-0002-5448-275X
  • Benitez, Leticia|||0000-0002-4950-036X
  • Genero, Mariona
  • Vieta, Eduard|||0000-0002-0548-0053
  • Gratacós, Eduard|||0000-0002-7405-7224
  • Crispi, Fatima|||0000-0002-7422-5240
  • Casas, Rosa|||0000-0002-0211-9166
Background: Non-time-consuming and easy-to-administer dietary assessment tools specific for pregnancy are needed. Objectives: The aim of this validation study nested in the IMPACT BCN (Improving Mothers for a better PrenAtal Care Trial BarCeloNa) trial is to determine the concurrent validity of the 17-item pregnancy-adapted Mediterranean diet score (preg-MEDAS) and to analyze whether changes in the preg-MEDAS score were associated with maternal favorable dietary and cardiometabolic changes after 3 mo of intervention in pregnant women. Methods: Dietary data was collected in 812 participants using the preg-MEDAS and a 151-item validated food frequency questionnaire (FFQ) at baseline (19-23 wk gestation) and final visit (31-34 wk gestation). Concurrent preg-MEDAS validity was evaluated by Pearson and intraclass correlation coefficients, κ statistic, and Bland-Altman methods. Results: The preg-MEDAS had a good correlation with the FFQ (r = 0.76 and intraclass correlation coefficient 0.75). The agreement of each of the preg-MEDAS items ranged from 40.9% to 93.8% with a substantial agreement mean concordance (κ = 0.61). A 2-point increase in preg-MEDAS was associated with a decrease in maternal mean and systolic blood pressure (β: -0.51 mmHg; 95% confidence interval [CI]: -0.97, -0.04 mmHg and -0.87 mmHg; 95% CI: -1.48, -0.26 mmHg, respectively). Conclusions: The preg-MEDAS displays good validity for assessing adherence to the Mediterranean diet, allowing detection of dietary changes over time. In addition, changes observed in preg-MEDAS are significantly associated with a decrease in maternal blood pressure. Therefore, we propose preg-MEDAS as a rapid and simple dietary assessment tool during pregnancy. This trial was registered at clinicaltrials.gov as NCT03166332.
Dipòsit Digital de Documents de la UAB
Publicación Artículo científico (JournalArticle)

Effect of Mediterranean diet or mindfulness-based stress reduction during pregnancy on placental volume and perfusion, A subanalysis of the IMPACT BCN randomized clinical trial

  • Nakaki, Ayako|||0000-0002-4395-3878
  • Denaro, Eugenio
  • Crimella, Maddalena
  • Castellani, Roberta
  • Vellvé, Kilian|||0000-0002-2376-7664
  • Izquierdo, Nora
  • Basso, Annachiara
  • Paules, Cristina|||0000-0001-6795-0367
  • Casas, Rosa|||0000-0002-0211-9166
  • Benitez, Leticia|||0000-0002-4950-036X
  • Casas, Irene
  • Larroya, Marta|||0000-0001-7929-6630
  • Genero, Mariona
  • Castro Barquero, Sara|||0000-0002-6876-5443
  • Gomez-Gomez, A|||0000-0001-8172-1827
  • Pozo, Oscar J|||0000-0002-1735-9728
  • Vieta, Eduard|||0000-0002-0548-0053
  • Estruch, Ramón|||0000-0003-1260-4445
  • Nadal, Alfons
  • Gratacós, Eduard|||0000-0002-7405-7224
  • Crovetto, Francesca|||0000-0003-0140-7411
  • Crispi, Fatima|||0000-0002-7422-5240
  • Youssef, Lina|||0000-0002-0554-5507
Introduction: The IMPACT BCN trial-a parallel-group randomized clinical trial where 1221 pregnant women at high risk for small-for-gestational age (SGA) newborns were randomly allocated at 19- to 23-week gestation into three groups: Mediterranean diet, Mindfulness-based Stress reduction or non-intervention-has demonstrated a positive effect of Mediterranean diet and Stress reduction in the prevention of SGA. However, the mechanism of action of these interventions remains still unclear. The aim of this study is to investigate the effect of Mediterranean diet and Stress reduction on placental volume and perfusion. Material and Methods: Participants in the Mediterranean diet group received monthly individual and group educational sessions, and free provision of extra-virgin olive oil and walnuts. Women in the Stress reduction group underwent an 8-week Stress reduction program adapted for pregnancy, consisting of weekly 2.5-h and one full-day sessions. Non-intervention group was based on usual care. Placental volume and perfusion were assessed in a subgroup of randomly selected women (n = 165) using magnetic resonance (MR) at 36-week gestation. Small placental volume was defined as MR estimated volume <10th centile. Perfusion was assessed by intravoxel incoherent motion. Results: While mean MR placental volume was similar among the study groups, both interventions were associated with a lower prevalence of small placental volume (3.9% Mediterranean diet and 5% stress reduction vs. 17% non-intervention; p = 0.03 and p = 0.04, respectively). Logistic regression showed that small placental volume was significantly associated with higher risk of SGA in both study groups (OR 7.48 [1.99-28.09] in Mediterranean diet and 20.44 [5.13-81.4] in Stress reduction). Mediation analysis showed that the effect of Mediterranean diet on SGA can be decomposed by a direct effect and an indirect effect (56.6%) mediated by a small placental volume. Similarly, the effect of Stress reduction on SGA is partially mediated (45.3%) by a small placental volume. Results on placental intravoxel incoherent motion perfusion fraction and diffusion coefficient were similar among the study groups. Conclusions: Structured interventions during pregnancy based on Mediterranean diet or Stress reduction are associated with a lower proportion of small placentas, which is consistent with the previously observed beneficial effects of these interventions on fetal growth.
Repisalud
Publicación Artículo científico (JournalArticle)

Mammographic density and breast cancer in women from high risk families

  • Ramón Y Cajal, Teresa
  • Chirivella, Isabel
  • Miranda, Josefa
  • Teule, Alexandre
  • Izquierdo, Angel
  • Balmaña, Judith
  • Sánchez-Heras, Ana Beatriz
  • Llort, Gemma
  • Fisas, David
  • Lope Carvajal, Virginia
  • Hernandez-Agudo, Elena
  • Juan-Fita, María José
  • Tena, Isabel
  • Robles, Luis
  • Guillén-Ponce, Carmen
  • Pérez-Segura, Pedro
  • Luque-Molina, Mari Sol
  • Hernando-Polo, Susana
  • Salinas, Mónica
  • Brunet, Joan
  • Salas-Trejo, Dolores
  • Barnadas, Agustí
  • Pollan-Santamaria, Marina
INTRODUCTION: Mammographic density (MD) is one of the strongest determinants of sporadic breast cancer (BC). In this study, we compared MD in BRCA1/2 mutation carriers and non-carriers from BRCA1/2 mutation-positive families and investigated the association between MD and BC among BRCA1/2 mutation carriers per type of mutation and tumor subtype. METHODS: The study was carried out in 1039 female members of BRCA1 and BRCA2 mutation-positive families followed at 16 Spanish Genetic Counseling Units. Participants' density was scored retrospectively from available mammograms by a single blinded radiologist using a 5-category scale (<10 %, 10-25 %, 25-50 %, 50-75 %, >75 %). In BC cases, we selected mammograms taken prior to diagnosis or from the contralateral breast, whereas, in non-cases, the last screening mammogram was evaluated. MD distribution in carriers and non-carriers was compared using ordinal logistic models, and the association between MD and BC in BRCA1/2 mutation carriers was studied using logistic regression. Huber-White robust estimators of variance were used to take into account correlations between family members. A similar multinomial model was used to explore this association by BC subtype. RESULTS: We identified and scored mammograms from 341 BRCA1, 350 BRCA2 mutation carriers and 229 non-carriers. Compared to non-carriers, MD was significantly lower among BRCA2 mutation carriers (odds ratio (OR) =0.71; P-value=0.04), but not among BRCA1 carriers (OR=0.84; P-value=0.33). MD was associated with subsequent development BC (OR per category of MD=1.45; 95 % confidence interval=1.18-1.78, P-value<0.001), with no significant differences between BRCA1 and BRCA2 mutation carriers (P-value=0.48). Finally, no statistically significant differences were observed in the association of MD with specific BC subtypes. CONCLUSIONS: Our study, the largest to date on this issue, confirms that MD is an independent risk factor for all BC subtypes in either BRCA1 and BRCA2 mutation carriers, and should be considered a phenotype risk marker in this context.
Repisalud
Publicación Artículo científico (JournalArticle)

Prediction of Breast and Prostate Cancer Risks in Male BRCA1 and BRCA2 Mutation Carriers Using Polygenic Risk Scores

  • Lecarpentier, Julie
  • Silvestri, Valentina
  • Kuchenbaecker, Karoline B
  • Barrowdale, Daniel
  • Dennis, Joe
  • McGuffog, Lesley
  • Soucy, Penny
  • Leslie, Goska
  • Rizzolo, Piera
  • Navazio, Anna Sara
  • Valentini, Virginia
  • Zelli, Veronica
  • Lee, Andrew
  • Amin Al Olama, Ali
  • Tyrer, Jonathan P
  • Southey, Melissa
  • John, Esther M
  • Conner, Thomas A
  • Goldgar, David E
  • Buys, Saundra S
  • Janavicius, Ramunas
  • Steele, Linda
  • Ding, Yuan Chun
  • Neuhausen, Susan L
  • Hansen, Thomas V O
  • Osorio, Ana
  • Weitzel, Jeffrey N
  • Toss, Angela
  • Medici, Veronica
  • Cortesi, Laura
  • Zanna, Ines
  • Palli, Domenico
  • Radice, Paolo
  • Manoukian, Siranoush
  • Peissel, Bernard
  • Azzollini, Jacopo
  • Viel, Alessandra
  • Cini, Giulia
  • Damante, Giuseppe
  • Tommasi, Stefania
  • Peterlongo, Paolo
  • Fostira, Florentia
  • Hamann, Ute
  • Evans, D Gareth
  • Henderson, Alex
  • Brewer, Carole
  • Eccles, Diana
  • Cook, Jackie
  • Ong, Kai-Ren
  • Walker, Lisa
  • Side, Lucy E
  • Porteous, Mary E
  • Davidson, Rosemarie
  • Hodgson, Shirley
  • Frost, Debra
  • Adlard, Julian
  • Izatt, Louise
  • Eeles, Ros
  • Ellis, Steve
  • Tischkowitz, Marc
  • Godwin, Andrew K
  • Meindl, Alfons
  • Gehrig, Andrea
  • Dworniczak, Bernd
  • Sutter, Christian
  • Engel, Christoph
  • Niederacher, Dieter
  • Steinemann, Doris
  • Hahnen, Eric
  • Hauke, Jan
  • Rhiem, Kerstin
  • Kast, Karin
  • Arnold, Norbert
  • Ditsch, Nina
  • Wang-Gohrke, Shan
  • Wappenschmidt, Barbara
  • Wand, Dorothea
  • Lasset, Christine
  • Stoppa-Lyonnet, Dominique
  • Belotti, Muriel
  • Damiola, Francesca
  • Barjhoux, Laure
  • Mazoyer, Sylvie
  • Van Heetvelde, Mattias
  • Poppe, Bruce
  • De Leeneer, Kim
  • Claes, Kathleen B M
  • de la Hoya, Miguel
  • Garcia-Barberan, Vanesa
  • Caldes, Trinidad
  • Perez Segura, Pedro
  • Kiiski, Johanna I
  • Aittomäki, Kristiina
  • Khan, Sofia
  • Nevanlinna, Heli
  • van Asperen, Christi J
  • Vaszko, Tibor
  • Kasler, Miklos
  • Olah, Edith
  • Balmaña, Judith
  • Gutiérrez-Enríquez, Sara
  • Diez, Orland
  • Teulé, Alex
  • Izquierdo, Angel
  • Darder, Esther
  • Brunet, Joan
  • Del Valle, Jesús
  • Feliubadalo, Lidia
  • Pujana, Miquel Angel
  • Lazaro, Conxi
  • Arason, Adalgeir
  • Agnarsson, Bjarni A
  • Johannsson, Oskar Th
  • Barkardottir, Rosa B
  • Alducci, Elisa
  • Tognazzo, Silvia
  • Montagna, Marco
  • Teixeira, Manuel R
  • Pinto, Pedro
  • Spurdle, Amanda B
  • Holland, Helene
  • Lee, Jong Won
  • Lee, Min Hyuk
  • Lee, Jihyoun
  • Kim, Sung-Won
  • Kang, Eunyoung
  • Kim, Zisun
  • Sharma, Priyanka
  • Rebbeck, Timothy R
  • Vijai, Joseph
  • Robson, Mark
  • Lincoln, Anne
  • Musinsky, Jacob
  • Gaddam, Pragna
  • Tan, Yen Y
  • Berger, Andreas
  • Singer, Christian F
  • Loud, Jennifer T
  • Greene, Mark H
  • Mulligan, Anna Marie
  • Glendon, Gord
  • Andrulis, Irene L
  • Toland, Amanda Ewart
  • Senter, Leigha
  • Bojesen, Anders
  • Nielsen, Henriette Roed
  • Skytte, Anne-Bine
  • Sunde, Lone
  • Jensen, Uffe Birk
  • Pedersen, Inge Sokilde
  • Krogh, Lotte
  • Kruse, Torben A
  • Caligo, Maria A
  • Yoon, Sook-Yee
  • Teo, Soo-Hwang
  • von Wachenfeldt, Anna
  • Huo, Dezheng
  • Nielsen, Sarah M
  • Olopade, Olufunmilayo I
  • Nathanson, Katherine L
  • Domchek, Susan M
  • Lorenchick, Christa
  • Jankowitz, Rachel C
  • Campbell, Ian
  • James, Paul
  • Mitchell, Gillian
  • Orr, Nick
  • Park, Sue Kyung
  • Thomassen, Mads
  • Offit, Kenneth
  • Couch, Fergus J
  • Simard, Jacques
  • Easton, Douglas F
  • Chenevix-Trench, Georgia
  • Schmutzler, Rita K
  • Antoniou, Antonis C
  • Ottini, Laura
Purpose BRCA1/2 mutations increase the risk of breast and prostate cancer in men. Common genetic variants modify cancer risks for female carriers of BRCA1/2 mutations. We investigated-for the first time to our knowledge-associations of common genetic variants with breast and prostate cancer risks for male carriers of BRCA1/ 2 mutations and implications for cancer risk prediction. Materials and Methods We genotyped 1,802 male carriers of BRCA1/2 mutations from the Consortium of Investigators of Modifiers of BRCA1/2 by using the custom Illumina OncoArray. We investigated the combined effects of established breast and prostate cancer susceptibility variants on cancer risks for male carriers of BRCA1/2 mutations by constructing weighted polygenic risk scores (PRSs) using published effect estimates as weights. Results In male carriers of BRCA1/2 mutations, PRS that was based on 88 female breast cancer susceptibility variants was associated with breast cancer risk (odds ratio per standard deviation of PRS, 1.36; 95% CI, 1.19 to 1.56; P = 8.6 × 10-6). Similarly, PRS that was based on 103 prostate cancer susceptibility variants was associated with prostate cancer risk (odds ratio per SD of PRS, 1.56; 95% CI, 1.35 to 1.81; P = 3.2 × 10-9). Large differences in absolute cancer risks were observed at the extremes of the PRS distribution. For example, prostate cancer risk by age 80 years at the 5th and 95th percentiles of the PRS varies from 7% to 26% for carriers of BRCA1 mutations and from 19% to 61% for carriers of BRCA2 mutations, respectively. Conclusion PRSs may provide informative cancer risk stratification for male carriers of BRCA1/2 mutations that might enable these men and their physicians to make informed decisions on the type and timing of breast and prostate cancer risk management.
Dipòsit Digital de Documents de la UAB
Publicación Artículo científico (JournalArticle)

Comprehensive establishment and characterization of orthoxenograft mouse models of malignant peripheral nerve sheath tumors for personalized medicine

  • Castellsagué, Joan|||0000-0002-2579-3137
  • Gel, Bernat|||0000-0001-8878-349X
  • Fernández-Rodríguez, Juana
  • Llatjós, Roger
  • Blanco Guillermo, Ignacio|||0000-0002-7414-7481
  • Benavente, Yolanda|||0000-0003-1422-4614
  • Pérez-Sidelnikova, Diana
  • Garcia del Muro, Xavier|||0000-0001-5571-2847
  • Viñals, Joan Maria
  • Vidal, August|||0000-0001-5727-2099
  • Valdés-Mas, Rafael
  • Terribas, Ernest
  • López-Doriga, Adriana
  • Pujana, Miguel Angel|||0000-0003-3222-4044
  • Capella, Gabriel|||0000-0002-4669-7320
  • Puente, Xose S.|||0000-0001-9525-1483
  • Serra, Eduard|||0000-0003-2895-9857
  • Villanueva Garatachea, Alberto
  • Lázaro García, Conxi|||0000-0002-7198-5906
Malignant peripheral nerve sheath tumors (MPNSTs) are soft-tissue sarcomas that can arise either sporadically or in association with neurofibromatosis type 1 (NF1). These aggressive malignancies confer poor survival, with no effective therapy available. We present the generation and characterization of five distinct MPNST orthoxenograft models for preclinical testing and personalized medicine. Four of the models are patient-derived tumor xenografts (PDTX), two independent MPNSTs from the same NF1 patient and two from different sporadic patients. The fifth model is an orthoxenograft derived from an NF1-related MPNST cell line. All MPNST orthoxenografts were generated by tumor implantation, or cell line injection, next to the sciatic nerve of nude mice, and were perpetuated by 7-10 mouse-to-mouse passages. The models reliably recapitulate the histopathological properties of their parental primary tumors. They also mimic distal dissemination properties in mice. Human stroma was rapidly lost after MPNST engraftment and replaced by murine stroma, which facilitated genomic tumor characterization. Compatible with an origin in a catastrophic event and subsequent genome stabilization, MPNST contained highly altered genomes that remained remarkably stable in orthoxenograft establishment and along passages. Mutational frequency and type of somatic point mutations were highly variable among the different MPNSTs modeled, but very consistent when comparing primary tumors with matched orthoxenografts generated. Unsupervised cluster analysis and principal component analysis (PCA) using an MPNST expression signature of ~1,000 genes grouped together all primary tumor-orthoxenograft pairs. Our work points to differences in the engraftment process of primary tumors compared with the engraftment of established cell lines. Following standardization and extensive characterization and validation, the orthoxenograft models were used for initial preclinical drug testing. Sorafenib (a BRAF inhibitor), in combination with doxorubicin or rapamycin, was found to be the most effective treatment for reducing MPNST growth. The development of genomically well-characterized preclinical models for MPNST allowed the evaluation of novel therapeutic strategies for personalized medicine.
Dipòsit Digital de Documents de la UAB
Publicación Artículo científico (JournalArticle)

Decapping protein EDC4 regulates DNA repair and phenocopies BRCA1

  • Hernández Viedma, Gonzalo|||0000-0002-3048-9607
  • Ramírez de Haro, Ma. José|||0000-0003-1417-7731
  • Minguillón Pedreño, Jordi|||0000-0003-2124-8294
  • Quiles, Francisco
  • Ruiz de Garibay, G.
  • Aza-Carmona, Miriam|||0000-0003-4448-9541
  • Bogliolo, Massimo|||0000-0001-8240-7784
  • Pujol Calvet, Maria Roser|||0000-0003-1840-5455
  • Prados-Carvajal, Rosario
  • Fernández-Rodríguez, Juana
  • García, Nadia
  • López, Adrià
  • Gutiérrez-Enríquez, Sara|||0000-0002-1711-6101
  • Diez, Orland|||0000-0001-7339-0570
  • Benitez, Javier|||0000-0002-0923-7202
  • Salinas, Monica
  • Teule, Alex|||0000-0003-0028-7200
  • Brunet, Joan|||0000-0003-1945-3512
  • Radice, Paolo|||0000-0001-6298-4111
  • Peterlongo, Paolo|||0000-0001-6951-6855
  • Schindler, Detlev
  • Huertas, Pablo
  • Puente, Xose P.
  • Lázaro, Coxi
  • Pujana, Miguel Angel|||0000-0003-3222-4044
  • Surralles, Jordi|||0000-0002-4041-7519
BRCA1 is a tumor suppressor that regulates DNA repair by homologous recombination. Germline mutations in BRCA1 are associated with increased risk of breast and ovarian cancer and BRCA1 deficient tumors are exquisitely sensitive to poly (ADP-ribose) polymerase (PARP) inhibitors. Therefore, uncovering additional components of this DNA repair pathway is of extreme importance for further understanding cancer development and therapeutic vulnerabilities. Here, we identify EDC4, a known component of processing-bodies and regulator of mRNA decapping, as a member of the BRCA1-BRIP1-TOPBP1 complex. EDC4 plays a key role in homologous recombination by stimulating end resection at double-strand breaks. EDC4 deficiency leads to genome instability and hypersensitivity to DNA interstrand cross-linking drugs and PARP inhibitors. Lack-of-function mutations in EDC4 were detected in BRCA1/2-mutation-negative breast cancer cases, suggesting a role in breast cancer susceptibility. Collectively, this study recognizes EDC4 with a dual role in decapping and DNA repair whose inactivation phenocopies BRCA1 deficiency.
Dipòsit Digital de Documents de la UAB
Publicación Artículo científico (JournalArticle)

A prospective prostate cancer screening programme for men with pathogenic variants in mismatch repair genes (IMPACT), initial results from an international prospective study

  • Bancroft, Elizabeth|||0000-0002-5482-5660
  • Page, Elizabeth C.
  • Brook, Mark N.|||0000-0002-8969-2378
  • Thomas, Sarah
  • Taylor, Natalie
  • Pope, Jennifer
  • McHugh, Jana
  • Jones, Ann-Britt
  • Karlsson, Questa
  • Merson, Susan
  • Ong, Kai Ren
  • Hoffman, Jonathan
  • Huber, Camilla
  • Maehle, Lovise
  • Grindedal, Eli Marie
  • Stormorken, Astrid
  • Evans, Gareth|||0000-0002-8482-5784
  • Rothwell, Jeanette
  • Lalloo, Fiona
  • Brady, Angela F.
  • Bartlett, Marion
  • Snape, Katie
  • Hanson, Helen
  • James, Paul|||0000-0002-4361-4657
  • McKinley, Joanne
  • Mascarenhas, Lyon
  • Syngal, Sapna
  • Ukaegbu, Chinedu
  • Side, Lucy
  • Thomas, Tessy
  • Barwell, Julian
  • Teixeira, Manuel R.|||0000-0002-4896-5982
  • Izatt, Louise|||0000-0003-1258-4843
  • Suri, Mohnish|||0000-0001-9037-701X
  • Macrae, Finlay A.
  • Poplawski, Nicola
  • Chen-Shtoyerman, Rakefet|||0000-0002-5055-5907
  • Ahmed, Munaza
  • Musgrave, Hannah
  • Nicolai, Nicola|||0000-0002-5718-2699
  • Greenhalgh, Lynn
  • Brewer, Carole
  • Pachter, Nicholas
  • Spigelman, Allan D.
  • Azzabi, Ashraf
  • Helfand, Brian T.
  • Halliday, Dorothy
  • Buys, Saundra|||0000-0003-4120-5697
  • Ramon y Cajal, Teresa|||0000-0003-3490-3585
  • Donaldson, Alan|||0000-0001-9193-4172
  • Cooney, Kathleen A.
  • Harris, Marion
  • McGrath, John
  • Davidson, Rosemarie
  • Taylor, Amy
  • Cooke, Peter
  • Myhill, Kathryn
  • Hogben, Matthew
  • Aaronson, Neil K.
  • Ardern-Jones, Audrey
  • Bangma, Chris H.
  • Castro, Elena|||0000-0002-3691-6454
  • Dearnaley, David|||0000-0002-3954-2806
  • Dias, Alexander
  • Dudderidge, Tim|||0000-0001-6373-3613
  • Eccles, Diana M.|||0000-0002-9935-3169
  • Green, Kate
  • Eyfjord, Jorunn
  • Falconer, Alison
  • Foster, Christopher S.
  • Gronberg, Henrik
  • Hamdy, Freddie C.|||0000-0003-2627-2154
  • Johannsson, Oskar
  • Khoo, Vincent
  • Lilja, Hans|||0000-0001-5871-7846
  • Lindeman, Geoffrey J.|||0000-0001-9386-2416
  • Lubinski, Jan|||0000-0003-2931-3003
  • Axcrona, Karol|||0000-0002-5011-0107
  • Mikropoulos, Christos|||0000-0001-8070-2851
  • Mitra, Anita V.
  • Moynihan, Clare
  • Ni Raghallaigh, Holly
  • Rennert, Gad|||0000-0002-8512-068X
  • Collier, Rebecca
  • Offman, Judith|||0000-0001-5604-1635
  • Kote-Jarai, Zsofia|||0000-0002-6329-5155
  • Eeles, Rosalind|||0000-0002-3698-6241
Lynch syndrome is a rare familial cancer syndrome caused by pathogenic variants in the mismatch repair genes MLH1, MSH2, MSH6, or PMS2, that cause predisposition to various cancers, predominantly colorectal and endometrial cancer. Data are emerging that pathogenic variants in mismatch repair genes increase the risk of early-onset aggressive prostate cancer. The IMPACT study is prospectively assessing prostate-specific antigen (PSA) screening in men with germline mismatch repair pathogenic variants. Here, we report the usefulness of PSA screening, prostate cancer incidence, and tumour characteristics after the first screening round in men with and without these germline pathogenic variants. The IMPACT study is an international, prospective study. Men aged 40-69 years without a previous prostate cancer diagnosis and with a known germline pathogenic variant in the MLH1, MSH2, or MSH6 gene, and age-matched male controls who tested negative for a familial pathogenic variant in these genes were recruited from 34 genetic and urology clinics in eight countries, and underwent a baseline PSA screening. Men who had a PSA level higher than 3·0 ng/mL were offered a transrectal, ultrasound-guided, prostate biopsy and a histopathological analysis was done. All participants are undergoing a minimum of 5 years' annual screening. The primary endpoint was to determine the incidence, stage, and pathology of screening-detected prostate cancer in carriers of pathogenic variants compared with non-carrier controls. We used Fisher's exact test to compare the number of cases, cancer incidence, and positive predictive values of the PSA cutoff and biopsy between carriers and non-carriers and the differences between disease types (ie, cancer vs no cancer, clinically significant cancer vs no cancer). We assessed screening outcomes and tumour characteristics by pathogenic variant status. Here we present results from the first round of PSA screening in the IMPACT study. This study is registered with , , and is now closed to accrual. Between Sept 28, 2012, and March 1, 2020, 828 men were recruited (644 carriers of mismatch repair pathogenic variants [204 carriers of MLH1, 305 carriers of MSH2, and 135 carriers of MSH6 ] and 184 non-carrier controls [65 non-carriers of MLH1, 76 non-carriers of MSH2, and 43 non-carriers of MSH6 ]), and in order to boost the sample size for the non-carrier control groups, we randomly selected 134 non-carriers from the BRCA1 and BRCA2 cohort of the IMPACT study, who were included in all three non-carrier cohorts. Men were predominantly of European ancestry (899 [93%] of 953 with available data), with a mean age of 52·8 years (SD 8·3). Within the first screening round, 56 (6%) men had a PSA concentration of more than 3·0 ng/mL and 35 (4%) biopsies were done. The overall incidence of prostate cancer was 1·9% (18 of 962; 95% CI 1·1-2·9). The incidence among MSH2 carriers was 4·3% (13 of 305; 95% CI 2·3-7·2), MSH2 non-carrier controls was 0·5% (one of 210; 0·0-2·6), MSH6 carriers was 3·0% (four of 135; 0·8-7·4), and none were detected among the MLH1 carriers, MLH1 non-carrier controls, and MSH6 non-carrier controls. Prostate cancer incidence, using a PSA threshold of higher than 3·0 ng/mL, was higher in MSH2 carriers than in MSH2 non-carrier controls (4·3% vs 0·5%; p=0·011) and MSH6 carriers than MSH6 non-carrier controls (3·0% vs 0%; p=0·034). The overall positive predictive value of biopsy using a PSA threshold of 3·0 ng/mL was 51·4% (95% CI 34·0-68·6), and the overall positive predictive value of a PSA threshold of 3·0 ng/mL was 32·1% (20·3-46·0). After the first screening round, carriers of MSH2 and MSH6 pathogenic variants had a higher incidence of prostate cancer compared with age-matched non-carrier controls. These findings support the use of targeted PSA screening in these men to identify those with clinically significant prostate cancer. Further annual screening rounds will need to confirm these findings.
Dipòsit Digital de Documents de la UAB
Publicación Artículo científico (JournalArticle)

Identification of independent association signals and putative functional variants for breast cancer risk through fine-scale mapping of the 12p11 locus

  • Zeng, Chenjie
  • Guo, Xingyi
  • Long, Jirong
  • Kuchenbaecker, Karoline B.
  • Droit, Arnaud
  • Michailidou, Kyriaki
  • Ghoussaini, Maya
  • Kar, Siddhartha
  • Freeman, Adam
  • Hopper, John L.
  • Milne, Roger L.|||0000-0001-5764-7268
  • Bolla, Manjeet K.|||0000-0002-4351-9326
  • Wang, Qin
  • Dennis, Joe|||0000-0003-4591-1214
  • Agata, Simona
  • Ahmed, Shahana
  • Aittomäki, Kristiina
  • Andrulis, Irene L.|||0000-0002-4226-6435
  • Anton-Culver, Hoda
  • Antonenkova, Natalia N.
  • Arason, Adalgeir|||0000-0003-0480-886X
  • Arndt, Volker|||0000-0001-9320-8684
  • Arun, Banu K.
  • Arver, Brita
  • Bacot, Francois
  • Barrowdale, Daniel|||0000-0003-1661-3939
  • Baynes, Caroline
  • Beeghly-Fadiel, Alicia|||0000-0001-9913-732X
  • Benitez, Javier|||0000-0002-0923-7202
  • Bermisheva, Marina
  • Blomqvist, Carl
  • Blot, William
  • Bogdanova, Natalia V.
  • Bojesen, Stig E.
  • Bonanni, Bernardo|||0000-0003-3589-2128
  • Borresen-Dale, Anne-Lise
  • Brand, Judith S.
  • Brauch, Hiltrud|||0000-0001-7531-2736
  • Brennan, Paul
  • Brenner, Hermann
  • Broeks, Annegien
  • Brüning, Thomas
  • Burwinkel, Barbara
  • Buys, Saundra|||0000-0003-4120-5697
  • Cai, Qiuyin
  • Caldes, Trinidad
  • Campbell, Ian|||0000-0002-7773-4155
  • Carpenter, Jane
  • Chang-Claude, Jenny
  • Choi, Ji-Yeob
  • Claes, Kathleen|||0000-0003-0841-7372
  • Clarke, Christine L.
  • Cox, Angela
  • Cross, Simon S.
  • Czene, Kamila
  • Daly, Mary B.
  • Hoya, Miguel de la|||0000-0002-8113-1410
  • De Leeneer, Kim
  • Devilee, Peter|||0000-0002-8023-2009
  • Diez, Orland|||0000-0001-7339-0570
  • Domchek, Susan M.|||0000-0002-5914-7272
  • Doody, Michele
  • Dorfling, Cecilia M.
  • Dörk, Thilo|||0000-0002-9458-0282
  • dos-Santos-Silva, Isabel
  • Dumont, Martine
  • Dwek, Miriam
  • Dworniczak, Bernd
  • Egan, Kathleen
  • Eilber, Ursula
  • Einbeigi, Zakaria
  • Ejlertsen, Bent
  • Ellis, Steve
  • Frost, Debra
  • Lalloo, Fiona
  • Fasching, Peter A.
  • Figueroa, Jonine
  • Flyger, Henrik
  • Friedlander, Michael|||0000-0003-3090-795X
  • Friedman, Eitan|||0000-0002-6745-1733
  • Gambino, Gaetana
  • Gao, Yu-Tang
  • Garber, Judy
  • García-Closas, Montserrat
  • Gehrig, Andrea
  • Damiola, Francesca
  • Lesueur, Fabienne|||0000-0001-7404-4549
  • Mazoyer, Sylvie
  • Stoppa-Lyonnet, Dominique
  • Giles, Graham G.
  • Godwin, Andrew K.|||0000-0002-3987-9580
  • Goldgar, David E.
  • González-Neira, Anna
  • Greene, Mark H.|||0000-0003-1852-9239
  • Guénel, Pascal
  • Haeberle, Lothar
  • Haiman, Christopher A.
  • Hallberg, Emily
  • Hamann, Ute|||0000-0001-6705-7624
  • Hansen, Thomas V. O.
  • Hart, Steven
  • Hartikainen, Jaana M.
  • Hartman, Mikael
  • Hassan, Norhashimah
  • Healey, Sue
  • Hogervorst, Frans B. L.
  • Verhoef, Senno
  • Hendricks, Carolyn B.
  • Hillemanns, Peter
  • Hollestelle, Antoinette
  • Hulick, Peter J.
  • Hunter, David J.
  • Imyanitov, Evgeny N.
  • Isaacs, Claudine|||0000-0002-9646-1260
  • Ito, Hidemi
  • Jakubowska, Anna|||0000-0002-5650-0501
  • Janavicius, Ramunas
  • Jaworska-Bieniek, Katarzyna
  • Jensen, Uffe Birk
  • John, Esther M.
  • Joly Beauparlant, Charles
  • Jones, Michael
  • Kabisch, Maria
  • Kang, Daehee
  • Karlan, Beth Y.|||0000-0002-9451-2933
  • Kauppila, Saila
  • Kerin, Michael J.
  • Khan, Sofia
  • Khusnutdinova, Elza
  • Knight, Julia A.
  • Konstantopoulou, Irene|||0000-0002-0470-0309
  • Kraft, Peter
  • Kwong, Ava
  • Laitman, Yael
  • Lambrechts, Diether
  • Lázaro García, Conxi|||0000-0002-7198-5906
  • Le Marchand, Loic
  • Lee, Chuen Neng
  • Lee, Min Hyuk
  • Lester, Jenny
  • Li, Jingmei
  • Liljegren, Annelie
  • Lindblom, Annika
  • Lophatananon, Artitaya
  • Lubinski, Jan|||0000-0003-2931-3003
  • Mai, Phuong L.
  • Mannermaa, Arto
  • Manoukian, Siranoush
  • Margolin, Sara
  • Marme, Frederik
  • Matsuo, Keitaro
  • McGuffog, Lesley|||0000-0003-1237-0546
  • Meindl, Alfons
  • Menegaux, Florence
  • Montagna, Marco
  • Muir, Kenneth
  • Mulligan, Anna Marie
  • Nathanson, Katherine L.|||0000-0002-6740-0901
  • Neuhausen, Susan L.|||0000-0001-5053-0390
  • Nevanlinna, Heli|||0000-0002-0916-2976
  • Newcomb, Polly A.
  • Nord, Silje
  • Nussbaum, Robert L.|||0000-0003-3445-8880
  • Offit, Kenneth
  • Olah, Edith
  • Olopade, Olufunmilayo I.|||0000-0002-9936-1599
  • Olswold, Curtis
  • Osorio, Ana|||0000-0001-8124-3984
  • Papi, Laura
  • Park-Simon, Tjoung-Won
  • Paulsson-Karlsson, Ylva
  • Peeters, Stephanie
  • Peissel, Bernard|||0000-0001-9233-3571
  • Peterlongo, Paolo|||0000-0001-6951-6855
  • Peto, Julian|||0000-0002-1685-8912
  • Pfeiler, Georg
  • Phelan, Catherine M.
  • Presneau, Nadege
  • Radice, Paolo|||0000-0001-6298-4111
  • Rahman, Nazneen
  • Ramus, Susan J.|||0000-0003-0005-7798
  • Rashid, Muhammad Usman
  • Rennert, Gad|||0000-0002-8512-068X
  • Rhiem, Kerstin
  • Rudolph, Anja
  • Salani, Ritu
  • Sangrajrang, Suleeporn
  • Sawyer, Elinor J.
  • Schmidt, Marjanka K.|||0000-0002-2228-429X
  • Schmutzler, Rita K.
  • Schoemaker, Minouk J.
  • Schürmann, Peter
  • Seynaeve, Caroline
  • Shen, Chen-Yang
  • Shrubsole, Martha J.
  • Shu, Xiao-Ou
  • Sigurdson, Alice
  • Singer, Christian F.
  • Slager, Susan|||0000-0002-5173-4712
  • Soucy, Penny
  • Southey, Melissa C.|||0000-0002-6313-9005
  • Steinemann, Doris|||0000-0001-8797-0816
  • Swerdlow, Anthony
  • Szabo, Csilla I.
  • Tchatchou, Sandrine
  • Teixeira, Manuel R.|||0000-0002-4896-5982
  • Teo, Soo|||0000-0002-0444-590X
  • Terry, Mary Beth
  • Tessier, Daniel C.
  • Teule, Alex|||0000-0003-0028-7200
  • Thomassen, Mads
  • Tihomirova, Laima
  • Tischkowitz, Marc
  • Toland, Amanda Ewart|||0000-0002-0271-1792
  • Tung, Nadine
  • Turnbull, Clare
  • van den Ouweland, Ans M. W.
  • van Rensburg, Elizabeth J.|||0000-0003-2077-230X
  • ven den Berg, David
  • Vijai, Joseph
  • Wang-Gohrke, Shan
  • Weitzel, Jeffrey N.
  • Whittemore, Alice S.
  • Winqvist, Robert
  • Wong, Tien Y.
  • Wu, Anna H.
  • Yannoukakos, Drakoulis
  • Yu, Jyh-Cherng
  • Pharoah, Paul D.P.|||0000-0001-8494-732X
  • Hall, Per
  • Chenevix-Trench, Georgia
  • Dunning, Alison M.
  • Simard, Jacques|||0000-0001-6906-3390
  • Couch, Fergus J.
  • Antoniou, Antonis C.
  • Easton, Douglas F.|||0000-0003-2444-3247
  • Zheng, Wei|||0000-0003-1226-070X
Multiple recent genome-wide association studies (GWAS) have identified a single nucleotide polymorphism (SNP), rs10771399, at 12p11 that is associated with breast cancer risk. We performed a fine-scale mapping study of a 700 kb region including 441 genotyped and more than 1300 imputed genetic variants in 48,155 cases and 43,612 controls of European descent, 6269 cases and 6624 controls of East Asian descent and 1116 cases and 932 controls of African descent in the Breast Cancer Association Consortium (BCAC; ), and in 15,252 BRCA1 mutation carriers in the Consortium of Investigators of Modifiers of BRCA1/2 (CIMBA). Stepwise regression analyses were performed to identify independent association signals. Data from the Encyclopedia of DNA Elements project (ENCODE) and the Cancer Genome Atlas (TCGA) were used for functional annotation. Analysis of data from European descendants found evidence for four independent association signals at 12p11, represented by rs7297051 (odds ratio (OR) = 1.09, 95 % confidence interval (CI) = 1.06-1.12; P = 3 × 10 -9), rs805510 (OR = 1.08, 95 % CI = 1.04-1.12, P = 2 × 10 -5), and rs1871152 (OR = 1.04, 95 % CI = 1.02-1.06; P = 2 × 10 -4) identified in the general populations, and rs113824616 (P = 7 × 10 -5) identified in the meta-analysis of BCAC ER-negative cases and BRCA1 mutation carriers. SNPs rs7297051, rs805510 and rs113824616 were also associated with breast cancer risk at P < 0.05 in East Asians, but none of the associations were statistically significant in African descendants. Multiple candidate functional variants are located in putative enhancer sequences. Chromatin interaction data suggested that PTHLH was the likely target gene of these enhancers. Of the six variants with the strongest evidence of potential functionality, rs11049453 was statistically significantly associated with the expression of PTHLH and its nearby gene CCDC91 at P < 0.05. This study identified four independent association signals at 12p11 and revealed potentially functional variants, providing additional insights into the underlying biological mechanism(s) for the association observed between variants at 12p11 and breast cancer risk. The online version of this article (doi:10.1186/s13058-016-0718-0) contains supplementary material, which is available to authorized users.
Dipòsit Digital de Documents de la UAB
Publicación Artículo científico (JournalArticle)

Assessing Associations between the AURKA-HMMR-TPX2-TUBG1 Functional Module and Breast Cancer Risk in BRCA1/2 Mutation Carriers

  • Blanco Guillermo, Ignacio|||0000-0002-7414-7481
  • Kuchenbaecker, Karoline|||0000-0001-9726-603X
  • Cuadras, Daniel|||0000-0001-8780-1764
  • Wang, Xianshu
  • Barrowdale, Daniel|||0000-0003-1661-3939
  • Ruiz de Garibay, Gorka|||0000-0001-9936-8419
  • Librado, Pablo
  • Sánchez-Gracia, Alejandro|||0000-0003-4543-4577
  • Rozas, Julio|||0000-0002-6839-9148
  • Bonifaci, Núria|||0000-0002-8193-6825
  • McGuffog, Lesley|||0000-0003-1237-0546
  • Pankratz, Vernon S.
  • Islam, Abul
  • Mateo, Francesca|||0000-0002-2342-7010
  • Berenguer-Llergo, Antoni|||0000-0002-3742-8161
  • Petit Montserrat, Anna|||0000-0002-9284-095X
  • Català, Isabel
  • Brunet, Joan|||0000-0003-1945-3512
  • Feliubadaló, Lidia|||0000-0002-1736-0112
  • Tornero, Eva
  • Benitez, Javier|||0000-0002-0923-7202
  • Osorio, Ana|||0000-0001-8124-3984
  • Ramon y Cajal, Teresa|||0000-0003-3490-3585
  • Aittomäki, Kristiina
  • Arun, Banu K.
  • Toland, Amanda Ewart|||0000-0002-0271-1792
  • Karlan, Beth Y.|||0000-0002-9451-2933
  • Walsh, Christine
  • Lester, Jenny
  • Greene, Mark H.|||0000-0003-1852-9239
  • Mai, Phuong L.
  • Nussbaum, Robert L.|||0000-0003-3445-8880
  • Andrulis, Irene L.|||0000-0002-4226-6435
  • Domchek, Susan M.|||0000-0002-5914-7272
  • Nathanson, Katherine L.|||0000-0002-6740-0901
  • Rebbeck, Timothy R.
  • Barkardottir, Rosa B.
  • Jakubowska, Anna|||0000-0002-5650-0501
  • Lubinski, Jan|||0000-0003-2931-3003
  • Durda, Katarzyna
  • Jaworska-Bieniek, Katarzyna
  • Claes, Kathleen|||0000-0003-0841-7372
  • Van Maerken, Tom
  • Diez, Orland|||0000-0001-7339-0570
  • Hansen, Thomas V.
  • Jønson, Lars
  • Gerdes, Anne-Marie
  • Ejlertsen, Bent
  • Hoya, Miguel de la|||0000-0002-8113-1410
  • Caldes, Trinidad
  • Dunning, Alison M.
  • Oliver, Clare
  • Fineberg, Elena
  • Cook, Margaret
  • Peock, Susan
  • McCann, Emma
  • Murray, Alex
  • Jacobs, Chris
  • Pichert, Gabriella
  • Lalloo, Fiona
  • Chu, Carol
  • Dorkins, Huw
  • Paterson, Joan
  • Ong, Kai-Ren
  • Teixeira, Manuel R.|||0000-0002-4896-5982
  • Hogervorst, Frans B. L.
  • van der Hout, Annemarie H.
  • Seynaeve, Caroline
  • van der Luijt, Rob B.
  • Ligtenberg, Marjolijn J. L.
  • Devilee, Peter|||0000-0002-8023-2009
  • Wijnen, Juul T.
  • Rookus, Matti A.
  • Meijers-Heijboer, Hanne E. J.
  • Blok, Marinus J.|||0000-0002-7935-5933
  • van den Ouweland, Ans M. W.
  • Aalfs, Cora M.
  • Rodriguez, Gustavo C.
  • Phillips, Kelly-Anne|||0000-0002-0475-1771
  • Piedmonte, Marion
  • Nerenstone, Stacy R.
  • Bae-Jump, Victoria L.
  • O'Malley, David M.
  • Ratner, Elena S.
  • Schmutzler, Rita K.
  • Wappenschmidt, Barbara
  • Rhiem, Kerstin
  • Engel, Christoph
  • Meindl, Alfons
  • Ditsch, Nina
  • Arnold, Norbert
  • Plendl, Hansjoerg J.
  • Niederacher, Dieter
  • Sutter, Christian|||0000-0003-4051-5888
  • Wang-Gohrke, Shan
  • Steinemann, Doris|||0000-0001-8797-0816
  • Preisler-Adams, Sabine
  • Kast, Karin|||0000-0001-6531-755X
  • Varon-Mateeva, Raymonda
  • Gehrig, Andrea
  • Bojesen, Anders|||0000-0003-4289-8595
  • Pedersen, Inge Sokilde
  • Sunde, Lone
  • Jensen, Uffe Birk
  • Thomassen, Mads
  • Kruse, Torben A.
  • Foretova, Lenka|||0000-0003-0494-2620
  • Peterlongo, Paolo|||0000-0001-6951-6855
  • Bernard, Loris
  • Peissel, Bernard|||0000-0001-9233-3571
  • Scuvera, Giulietta
  • Manoukian, Siranoush
  • Radice, Paolo|||0000-0001-6298-4111
  • Ottini, Laura
  • Montagna, Marco
  • Agata, Simona
  • Maugard, Christine
  • Simard, Jacques|||0000-0001-6906-3390
  • Soucy, Penny
  • Berger, Andreas|||0000-0001-5865-6609
  • Fink-Retter, Anneliese
  • Singer, Christian F.
  • Rappaport, Christine
  • Geschwantler-Kaulich, Daphne
  • Tea, Muy-Kheng
  • Pfeiler, Georg
  • John, Esther M.
  • Miron, Alex
  • Neuhausen, Susan L.|||0000-0001-5053-0390
  • Terry, Mary Beth
  • Chung, Wendy
  • Daly, Mary B.
  • Goldgar, David E.
  • Janavicius, Ramunas
  • Dorfling, Cecilia M.
  • van Rensburg, Elisabeth J.
  • Fostira, Florentia
  • Konstantopoulou, Irene|||0000-0002-0470-0309
  • Garber, Judy
  • Godwin, Andrew K.|||0000-0002-3987-9580
  • Olah, Edith
  • Narod, Steven A.
  • Rennert, Gad|||0000-0002-8512-068X
  • Paluch, Shani Shimon
  • Laitman, Yael
  • Friedman, Eitan|||0000-0002-6745-1733
  • Liljegren, Annelie
  • Rantala, Johanna
  • Stenmark-Askmalm, Marie
  • Loman, Niklas
  • Imyanitov, Evgeny N.
  • Hamann, Ute|||0000-0001-6705-7624
  • Spurdle, Amanda B.
  • Healey, Sue
  • Weitzel, Jeffrey N.
  • Herzog, Josef
  • Margileth, David
  • Gorrini, Chiara
  • Esteller, M.|||0000-0003-4490-6093
  • Gómez Moruno, Antonio|||0000-0001-5308-981X
  • Sayols, Sergi|||0000-0002-3877-4170
  • Vidal, Enrique
  • Heyn, Holger|||0000-0002-3276-1889
  • Stoppa-Lyonnet, Dominique
  • Léoné, Melanie
  • Barjhoux, Laure
  • Fassy-Colcombet, Marion
  • De Pauw, Antoine|||0000-0003-3898-073X
  • Lasset, Christine
  • Ferrer, Sandra Fert
  • Castera, Laurent
  • Berthet, Pascaline
  • Cornelis, François
  • Bignon, Yves-Jean
  • Damiola, Francesca
  • Mazoyer, Sylvie
  • Sinilnikova, Olga M.
  • Maxwell, Christopher A.
  • Vijai, Joseph
  • Robson, Mark
  • Kauff, Noah
  • Corines, Marina|||0000-0001-8472-4046
  • Villano, Danylko
  • Cunningham, Julie M.
  • Lee, Adam
  • Lindor, Noralane M.
  • Lázaro García, Conxi|||0000-0002-7198-5906
  • Easton, Douglas F.|||0000-0003-2444-3247
  • Offit, Kenneth
  • Chenevix-Trench, Georgia
  • Couch, Fergus J.
  • Antoniou, Antonis C.
  • Pujana, Miguel Angel|||0000-0003-3222-4044
While interplay between BRCA1 and AURKA-RHAMM-TPX2-TUBG1 regulates mammary epithelial polarization, common genetic variation in HMMR (gene product RHAMM) may be associated with risk of breast cancer in BRCA1 mutation carriers. Following on these observations, we further assessed the link between the AURKA-HMMR-TPX2-TUBG1 functional module and risk of breast cancer in BRCA1 or BRCA2 mutation carriers. Forty-one single nucleotide polymorphisms (SNPs) were genotyped in 15,252 BRCA1 and 8,211 BRCA2 mutation carriers and subsequently analyzed using a retrospective likelihood approach. The association of HMMR rs299290 with breast cancer risk in BRCA1 mutation carriers was confirmed: per-allele hazard ratio (HR) = 1.10, 95% confidence interval (CI) 1.04 - 1.15, p = 1.9 x 10 -4 (false discovery rate (FDR)-adjusted p = 0.043). Variation in CSTF1, located next to AURKA, was also found to be associated with breast cancer risk in BRCA2 mutation carriers: rs2426618 per-allele HR = 1.10, 95% CI 1.03 - 1.16, p = 0.005 (FDR-adjusted p = 0.045). Assessment of pairwise interactions provided suggestions (FDR-adjusted p values.
Dipòsit Digital de Documents de la UAB
Publicación Artículo científico (JournalArticle)

An original phylogenetic approach identified mitochondrial haplogrou,p T1a1 as inversely associated with breast cancer risk in BRCA2 mutation carriers

  • Blein, Sophie
  • Bardel, Claire
  • Danjean, Vincent
  • McGuffog, Lesley|||0000-0003-1237-0546
  • Healey, Sue
  • Barrowdale, Daniel|||0000-0003-1661-3939
  • Lee, Andrew
  • Dennis, Joe|||0000-0003-4591-1214
  • Kuchenbaecker, Karoline B.
  • Soucy, Penny
  • Terry, Mary Beth
  • Chung, Wendy
  • Goldgar, David E.
  • Buys, Saundra|||0000-0003-4120-5697
  • Janavicius, Ramunas
  • Tihomirova, Laima
  • Tung, Nadine
  • Dorfling, Cecilia M.
  • van Rensburg, Elizabeth J.|||0000-0003-2077-230X
  • Neuhausen, Susan L.|||0000-0001-5053-0390
  • Ding, Yuan Chun
  • Gerdes, Anne-Marie
  • Ejlertsen, Bent
  • Nielsen, Finn C.
  • Hansen, Thomas V. O.
  • Osorio, Ana|||0000-0001-8124-3984
  • Benitez, Javier|||0000-0002-0923-7202
  • Andrés Conejero, Raquel
  • Segota, Ena
  • Weitzel, Jeffrey N.
  • Thelander, Margo
  • Peterlongo, Paolo|||0000-0001-6951-6855
  • Radice, Paolo|||0000-0001-6298-4111
  • Pensotti, Valeria
  • Dolcetti, Riccardo
  • Bonanni, Bernardo|||0000-0003-3589-2128
  • Peissel, Bernard|||0000-0001-9233-3571
  • Zaffaroni, Daniela|||0000-0002-6995-2216
  • Scuvera, Giulietta
  • Manoukian, Siranoush
  • Varesco, Liliana
  • Capone, Gabriele L.
  • Papi, Laura
  • Ottini, Laura
  • Yannoukakos, Drakoulis
  • Konstantopoulou, Irene|||0000-0002-0470-0309
  • Garber, Judy
  • Hamann, Ute|||0000-0001-6705-7624
  • Donaldson, Alan|||0000-0001-9193-4172
  • Brady, Angela
  • Brewer, Carole
  • Foo, Claire
  • Evans, Gareth|||0000-0002-8482-5784
  • Frost, Debra
  • Eccles, Diana M.|||0000-0002-9935-3169
  • Douglas, Fiona
  • Cook, Jackie
  • Adlard, Julian|||0000-0002-1693-0435
  • Barwell, Julian
  • Walker, Lisa
  • Izatt, Louise|||0000-0003-1258-4843
  • Side, Lucy E.
  • Kennedy, M. John
  • Tischkowitz, Marc
  • Rogers, Mark T.
  • Porteous, Mary E.
  • Morrison, Patrick J.
  • Platte, Radka
  • Eeles, Rosalind|||0000-0002-3698-6241
  • Davidson, Rosemarie
  • Hodgson, Shirley
  • Cole, Trevor
  • Godwin, Andrew K.|||0000-0002-3987-9580
  • Isaacs, Claudine|||0000-0002-9646-1260
  • Claes, Kathleen|||0000-0003-0841-7372
  • De Leeneer, Kim
  • Meindl, Alfons
  • Gehrig, Andrea
  • Wappenschmidt, Barbara
  • Sutter, Christian|||0000-0003-4051-5888
  • Engel, Christoph
  • Niederacher, Dieter
  • Steinemann, Doris|||0000-0001-8797-0816
  • Plendl, Hansjoerg
  • Kast, Karin|||0000-0001-6531-755X
  • Rhiem, Kerstin
  • Ditsch, Nina
  • Arnold, Norbert
  • Varon-Mateeva, Raymonda
  • Schmutzler, Rita K.
  • Preisler-Adams, Sabine
  • Markov, Nadja Bogdanova
  • Wang-Gohrke, Shan
  • De Pauw, Antoine|||0000-0003-3898-073X
  • Lefol, Cédrick
  • Lasset, Christine
  • Leroux, Dominique
  • Rouleau, Etienne
  • Damiola, Francesca
  • Dreyfus, Hélène
  • Barjhoux, Laure
  • Golmard, Lisa
  • Uhrhammer, Nancy
  • Bonadona, Valérie
  • Sornin, Valérie
  • Bignon, Yves-Jean
  • Carter, Jonathan
  • Van Le, Linda
  • Piedmonte, Marion
  • DiSilvestro, Paul A.
  • Hoya, Miguel de la|||0000-0002-8113-1410
  • Caldes, Trinidad
  • Nevanlinna, Heli|||0000-0002-0916-2976
  • Aittomäki, Kristiina
  • Jager, Agnes
  • van den Ouweland, Ans M. W.
  • Kets, Carolien M.
  • Aalfs, Cora M.
  • van Leeuwen, Flora E.
  • Hogervorst, Frans B. L.
  • Meijers-Heijboer, Hanne E. J.
  • Oosterwijk, Jan C.
  • van Roozendaal, Kees E. P.
  • Rookus, Matti A.
  • Devilee, Peter|||0000-0002-8023-2009
  • van der Luijt, Rob B.
  • Olah, Edith
  • Diez, Orland|||0000-0001-7339-0570
  • Teule, Alex|||0000-0003-0028-7200
  • Lázaro García, Conxi|||0000-0002-7198-5906
  • Blanco Guillermo, Ignacio|||0000-0002-7414-7481
  • Del Valle, Jesús|||0000-0003-3607-7045
  • Jakubowska, Anna|||0000-0002-5650-0501
  • Sukiennicki, Grzegorz
  • Gronwald, Jacek
  • Lubinski, Jan|||0000-0003-2931-3003
  • Durda, Katarzyna
  • Jaworska-Bieniek, Katarzyna
  • Agnarsson, Bjarni A.
  • Maugard, Christine
  • Amadori, Alberto
  • Montagna, Marco
  • Teixeira, Manuel R.|||0000-0002-4896-5982
  • Spurdle, Amanda B.
  • Foulkes, William|||0000-0001-7427-4651
  • Olswold, Curtis
  • Lindor, Noralane M.
  • Pankratz, Vernon S.
  • Szabo, Csilla I.
  • Lincoln, Anne
  • Jacobs, Lauren
  • Corines, Marina|||0000-0001-8472-4046
  • Robson, Mark
  • Vijai, Joseph
  • Berger, Andreas|||0000-0001-5865-6609
  • Fink-Retter, Anneliese
  • Singer, Christian F.
  • Rappaport, Christine
  • Kaulich, Daphne Geschwantler
  • Pfeiler, Georg
  • Tea, Muy-Kheng
  • Greene, Mark H.|||0000-0003-1852-9239
  • Mai, Phuong L.
  • Rennert, Gad|||0000-0002-8512-068X
  • Imyanitov, Evgeny N.
  • Mulligan, Anna Marie
  • Glendon, Gord
  • Andrulis, Irene L.|||0000-0002-4226-6435
  • Tchatchou, Sandrine
  • Toland, Amanda Ewart|||0000-0002-0271-1792
  • Pedersen, Inge Sokilde
  • Thomassen, Mads
  • Kruse, Torben A.
  • Jensen, Uffe Birk
  • Caligo, Maria|||0000-0003-0589-1829
  • Friedman, Eitan|||0000-0002-6745-1733
  • Zidan, Jamal
  • Laitman, Yael
  • Lindblom, Annika
  • Melin, Beatrice
  • Arver, Brita
  • Loman, Niklas
  • Rosenquist, Richard|||0000-0002-0211-8788
  • Olopade, Olufunmilayo I.|||0000-0002-9936-1599
  • Nussbaum, Robert L.|||0000-0003-3445-8880
  • Ramus, Susan J.|||0000-0003-0005-7798
  • Nathanson, Katherine L.|||0000-0002-6740-0901
  • Domchek, Susan M.|||0000-0002-5914-7272
  • Rebbeck, Timothy R.
  • Arun, Banu K.
  • Mitchell, Gillian
  • Karlan, Beth Y.|||0000-0002-9451-2933
  • Lester, Jenny
  • Orsulic, Sandra|||0000-0001-5119-8721
  • Stoppa-Lyonnet, Dominique
  • Thomas, Gilles
  • Simard, Jacques|||0000-0001-6906-3390
  • Couch, Fergus J.
  • Offit, Kenneth
  • Easton, Douglas F.|||0000-0003-2444-3247
  • Chenevix-Trench, Georgia
  • Antoniou, Antonis C.
  • Mazoyer, Sylvie
  • Phelan, Catherine M.
  • Sinilnikova, Olga M.
  • Cox, David G.
Individuals carrying pathogenic mutations in the BRCA1 and BRCA2 genes have a high lifetime risk of breast cancer. BRCA1 and BRCA2 are involved in DNA double-strand break repair, DNA alterations that can be caused by exposure to reactive oxygen species, a main source of which are mitochondria. Mitochondrial genome variations affect electron transport chain efficiency and reactive oxygen species production. Individuals with different mitochondrial haplogroups differ in their metabolism and sensitivity to oxidative stress. Variability in mitochondrial genetic background can alter reactive oxygen species production, leading to cancer risk. In the present study, we tested the hypothesis that mitochondrial haplogroups modify breast cancer risk in BRCA1/2 mutation carriers. We genotyped 22,214 (11,421 affected, 10,793 unaffected) mutation carriers belonging to the Consortium of Investigators of Modifiers of BRCA1/2 for 129 mitochondrial polymorphisms using the iCOGS array. Haplogroup inference and association detection were performed using a phylogenetic approach. ALTree was applied to explore the reference mitochondrial evolutionary tree and detect subclades enriched in affected or unaffected individuals. We discovered that subclade T1a1 was depleted in affected BRCA2 mutation carriers compared with the rest of clade T (hazard ratio (HR) = 0.55; 95% confidence interval (CI), 0.34 to 0.88; P = 0.01). Compared with the most frequent haplogroup in the general population (that is, H and T clades), the T1a1 haplogroup has a HR of 0.62 (95% CI, 0.40 to 0.95; P = 0.03). We also identified three potential susceptibility loci, including G13708A/rs28359178, which has demonstrated an inverse association with familial breast cancer risk. This study illustrates how original approaches such as the phylogeny-based method we used can empower classical molecular epidemiological studies aimed at identifying association or risk modification effects. The online version of this article (doi:10.1186/s13058-015-0567-2) contains supplementary material, which is available to authorized users.
Dipòsit Digital de Documents de la UAB
Publicación Artículo científico (JournalArticle)

Maternal Stress, Anxiety, Well-Being, and Sleep Quality in Pregnant Women throughout Gestation

  • Pascal, Rosalia|||0000-0003-3874-7524
  • Casas, Irene
  • Genero, Mariona
  • Nakaki, Ayako|||0000-0002-4395-3878
  • Youssef, Lina|||0000-0002-0554-5507
  • Larroya, Marta|||0000-0001-7929-6630
  • Benitez, Leticia|||0000-0002-4950-036X
  • Gomez, Yvan|||0000-0003-0794-7750
  • Martínez-Àran, Anabel|||0000-0002-0623-6263
  • Morilla, Ivette
  • Oller Guzmán, Teresa
  • Martín-Asuero, Andrés
  • Vieta, Eduard|||0000-0002-0548-0053
  • Crispi, Fatima|||0000-0002-7422-5240
  • Gratacós, Eduard|||0000-0002-7405-7224
  • Gómez-Roig, María Dolores|||0000-0003-2329-1851
  • Crovetto, Francesca|||0000-0003-0140-7411
Background: Maternal stress, anxiety, well-being, and sleep quality during pregnancy have been described as influencing factors during pregnancy. Aim: We aimed to describe maternal stress, anxiety, well-being, and sleep quality in pregnant women throughout gestation and their related factors. Methods: A prospective study including pregnant women attending BCNatal, in Barcelona, Spain (n = 630). Maternal stress and anxiety were assessed by the Perceived Stress Scale (PSS) and State-Trait Anxiety Inventory (STAI)-validated questionnaires. Maternal well-being was assessed using the World Health Organization Well-Being Index Questionnaire (WHO-5), and sleep quality was assessed using the Pittsburgh Sleep Quality Index Questionnaire (PSQI). All questionnaires were obtained twice during the second and third trimester of pregnancy. A multivariate analysis was conducted to assess factors related to higher maternal stress and anxiety and worse well-being and sleep quality. Results: High levels of maternal stress were reported in 23.1% of participants at the end of pregnancy, with maternal age <40 years (OR 2.02; 95% CI 1.08-3.81, p = 0.03), non-white ethnicity (OR 2.09; 95% CI 1.19-4.02, p = 0.01), and non-university studies (OR 1.86; 95% CI 1.08-3.19, p = 0.02) being the parameters mostly associated with it. A total of 20.7% of women had high levels of anxiety in the third trimester and the presence of psychiatric disorders (OR 3.62; 95% CI 1.34-9.78, p = 0.01) and non-university studies (OR 1.70; 95% CI 1.11-2.59, p = 0.01) provided a significant contribution to high anxiety at multivariate analysis. Poor maternal well-being was observed in 26.5% of women and a significant contribution was provided by the presence of psychiatric disorders (OR 2.96; 95% CI 1.07-8.25, p = 0.04) and non-university studies (OR 1.74; 95% CI 1.10-2.74, p = 0.02). Finally, less sleep quality was observed at the end of pregnancy (p < 0.001), with 81.1% of women reporting poor sleep quality. Conclusion: Maternal stress and anxiety, compromised maternal well-being, and sleep quality disturbances are prevalent throughout pregnancy. Anxiety and compromised sleep quality may increase over gestation. The screening of these conditions at different stages of pregnancy and awareness of the associated risk factors can help to identify women at potential risk.